Ti-Com sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-07-23
Share capital
10,000.00 PLN
Activity description

Ti-Com is a Contract Research Organization that specializes in preclinical research using large animal models to test drugs and medical devices for central nervous system diseases. They utilize image-guided procedures, particularly an endovascular model of stroke in pigs, to enhance precision in testing biomarkers, diagnostics, and therapeutic agents. Their services include project logistics management and behavioral testing to support the development of new treatments.

Registered address
ul. Władysława Trylińskiego 2, 10-683 Olsztyn, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-87883-94335-EIIUW-22

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 40 days late).

  • 202501/04/2026
  • 202418/06/2025
  • 202302/07/2024
  • 202213/07/2023
  • 202124/08/2022
  • 202019/02/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 74%
Sector · Manufacturing18,621 / 24,548
Top 76%
City · Olsztyn1,044 / 1,892
Top 55%
Voivodeship · Warmińsko-Mazurskie3,415 / 5,923
Top 58%
Country · Poland176,036 / 297,069
Top 59%

Results vs industry

Revenue
This companyUSD 157.55kMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 21.48kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 131.97kMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 95.27kMedianUSD 897.46kAverageUSD 31.52m

Offer

Websites

Job offers

The company has its own careers page: ticomglobal.com/about-us.

Authorized Representatives

Dominika Gołubczyk age 34 – President of the Management Board

Manner of representation

The persons authorised to make declarations of will in property and non-property matters and to sign on behalf of the company are: in the event of a one-person management board – a member of the management board independently; in the event of a multi-member management board – two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
39$526.7419.5%
80$1,080.5040%
75$1,012.9737.5%
Maciej Daciewicz
6$81.043%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-12-10.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

European Funds

ProjectEU co-financing
Engineering vascularized implants for personalised osteochondral tissue regeneration: from medical imaging to pre-clinical validation
$114.3K

Competitors

Name
MDR Regulator sp. z o.o.
Green Zebras S.A.
Globe Badania Kliniczne sp. z o.o.
Genelytica sp. z o.o.
TCI sp. z o.o.
Pharmaxi Poland sp. z o.o.
Clinical Medical Research II sp. z o.o.
Centrum Analiz Sądowych i Badań Kryminalistycznych sp. z o.o.
HTA Registry sp. z o.o.
Zawamed sp. z o.o.

Change history

DateEvent
2023-08-24Share capital increase
2018-07-23Entered in the register

FAQ

Last updated: 2026-04-02